Nanjing SemiDrive Technology has completed a 500 million yuan ($73 million) Series A round led by CTC Capital, while Qiming Venture Partners has led a 350 million yuan ($51 million) Series B round in MEDx Translational Medicine.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
